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Abstract The crystal structure of full-length Csk (C-terminal
Src kinase) molecules shows a hydrophobic interaction between
the SH2^kinase linker residue Phe183 and the KC-helix of the
catalytic domain. To study the possible involvement of this con-
tact in the regulation of the activity of Csk and CHK (Csk
homologous kinase), a Csk SH2^kinase linker deletion mutant,
Csk Phe183 and CHK Leu223 point mutants were analyzed. It
was observed that a residue with a long hydrophobic side chain
in position 183 (Csk) and 223 (CHK) is required to sustain the
catalytic activity of Csk and CHK. These results suggest that
Csk Phe183 and CHK Leu223 stabilize the movement of the
KC-helix of these protein tyrosine kinases.
- 2003 Federation of European Biochemical Societies. Pub-
lished by Elsevier Science B.V. All rights reserved.
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1. Introduction
Csk (C-terminal Src kinase) is a ubiquitously expressed 50
kDa protein tyrosine kinase, the main function of which is to
downregulate the catalytic activity of Src-family kinases [1^3].
Together with CHK (Csk homologous kinase) [4] it belongs to
the Csk-family of non-receptor tyrosine kinases. Csk is a mod-
ular protein consisting of SH3-, SH2- and kinase domains.
However, Csk is unique among the tyrosine kinases because
it lacks a conserved tyrosine autophosphorylation site in the
kinase domain. Furthermore, Csk does not possess a myris-
tylation site in the N-terminus or a regulatory phosphotyro-
sine site in the C-terminal tail.
Several studies have shown that the catalytic activity of Csk
can be modulated to some extent [5^7]. The crystal structure
of four active and two inactive full-length Csk molecules pro-
vides the molecular basis to study how control of Csk activity
is achieved [8]. The crystal data show that in all Csk mole-
cules, the SH3 and SH2 domains align on top of, but on
opposite sides of the N-terminal lobe of the kinase domain.
Furthermore, both the SH3^SH2^ and the SH2^kinase linkers
make extensive interactions with the kinase domain (Fig. 1A).
The crystal data also show that in inactive Csk molecules, the
SH2 domains are rotated upward, resulting in loss of some of
the contacts between the SH2- and the kinase domain.
It is not precisely known which of the intramolecular inter-
actions created by the SH2 domain, the SH3^SH2 linker and
the SH2^kinase linker are essential for the catalytic activity of
Csk or how these interactions regulate Csk activity. Thus far
it has been shown that site-directed mutagenesis of SH3^SH2
linker residues decreases catalytic activity of Csk, indicating
the importance of the SH3^SH2 linker for Csk activity [9].
The SH2^kinase linker of Src plays a critical role in the
inactivation of Src. The side chain of Leu255, within the
SH2^kinase linker, must be inserted into a hydrophobic pock-
et on the surface of the N-terminal lobe of the kinase domain
to inactivate Src [10]. Interestingly, both Csk and CHK have
in their SH2^kinase linker a residue with a long hydrophobic
side chain at a position corresponding to Src Leu255 (Fig.
2A). These amino acid residues are Phe183 (Csk) and
Leu223 (CHK), respectively. In the crystal structure of active
and inactive Csk molecules, Phe183 lies within a short K-helix,
designated KBC, and makes contact with the KC-helix in the
N-terminal lobe of the kinase domain (Fig. 1A,B). Therefore,
it is possible that conserved hydrophobicity in the SH2^kinase
linker of Csk plays a role in the stabilization of the active
conformation of the KC-helix.
In the present study, the role of conserved hydrophobicity
in the SH2^kinase linker region as an aspect of the regulation
of Csk-family kinases was analyzed. Deletion and site-directed
mutagenesis revealed that the long hydrophobic side chain of
Phe183 in Csk and Leu223 in CHK in the SH2^kinase linker
region are required to maintain the full catalytic activity of
Csk-family kinases. These data provide evidence that engage-
ment of a hydrophobic SH2^kinase linker residue with the
KC-helix is required for formation of a catalytically functional
domain of the Csk-family kinases.
2. Materials and methods
2.1. Cell culture
HeLa tet-o¡ cells (Clontech) expressing the tetracycline-controlled
transactivator and COS-1 cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium (BioWhittaker) supplemented with 10% (v/v), 2 mM
L-glutamine and 100 U/ml penicillin ^ 100 Wg/ml streptomycin (Bio-
Whittaker).
2.2. Plasmid constructs
Csk constructs (Fig. 2B) were generated using either the Altered
Sites in vitro Mutagenesis System (Promega) or the QuickChange
site-directed mutagenesis method (Stratagene). In the Altered Sites
Mutagenesis System mutations were introduced into human csk
cDNA in the pALTER vector (Promega). Desirable mutations were
con¢rmed by sequencing the relevant regions. The mutated Csk in-
serts were excised from pALTER vectors and subcloned into pUHD
vectors [11] for expression in HeLa tet-o¡ cells. In the QuickChange
mutagenesis method mutations were introduced directly into human
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csk cDNA in the pUHD vector. CHK constructs (Fig. 2B) were
generated using the QuickChange mutagenesis method and the
pcDNA3FLAG-CHK vector [12] (a generous gift of Dr. Hava Avra-
ham, Harvard Medical School, Boston, MA, USA)
2.3. Transfections, cell lysis and Western blotting
Wild-type (wt) and mutant pUHDCsk vectors were transfected into
HeLa tet-o¡ cells using FuGENE 6 according to the manufacturer’s
protocol (Roche Diagnostics) or the calcium phosphate method [13].
pcDNA3FLAG-CHK wt and mutant constructs were transfected into
COS-1 cells using the calcium phosphate method.
After 48^72 h cell culture, transfected cells were scraped o¡ the
plates and disrupted in lysis bu¡er (20 mM HEPES pH 7.4, 150
mM NaCl, 5 mM EDTA, 1% Nonidet P40, 1 mM phenylmethylsul-
fonyl £uoride, 10 Wg/ml aprotinin, 2 mM NaVO4, 50 mM NaF) for 20
min at 4‡C. Undissolved material was removed by centrifugation of
lysates for 15 min at 11 000Ug. The protein concentration of cell
extracts was determined using BCA Protein Assay (Pierce). Proteins
were resolved in sodium dodecyl sulfate^polyacrylamide gel and elec-
trophoretically transferred to nitrocellulose membranes. The mem-
branes were blocked using 4% (w/v) bovine serum albumin (BSA) in
Tris-bu¡ered saline^Tween (10 mM Tris^HCl, pH 7.4, 150 mM NaCl,
0.05% (v/v) Tween 20). Speci¢c proteins were detected using rabbit
antiserum against Csk [14] or rabbit polyclonal antibodies against Csk
(Santa Cruz Biotechnology), CHK (Lsk; Santa Cruz Biotechnology)
and FLAG epitope (Sigma Aldrich) combined with horseradish per-
oxidase-linked secondary antibodies (Amersham Biosciences). Immu-
nodetection was performed by enhanced chemiluminescence (Amer-
sham Pharmacia Biotech). To equalize the amounts of overexpressed
kinases in immunoprecipitations, expression levels of Csk and CHK
from immunoblots were quanti¢ed using Image Pro plus software
(Media Cybernetics).
2.4. Immunoprecipitations and kinase reaction
Equal amounts of overexpressed Csk and CHK were immunopre-
cipitated by speci¢ed antibodies. At least 500 Wg of total protein was
incubated with kinase-speci¢c antibodies for 1 h at 4‡C. Protein A^
Sepharose (Amersham Biosciences) was added and incubation was
continued for 0.5 h. Immunoprecipitates were centrifuged and washed
three times with lysis bu¡er and twice with kinase bu¡er (10 mM
HEPES pH 7.4, 5 mM MnCl2). Kinase reaction was started by adding
to the immunoprecipitates (25 Wl bead volume) 5 Wl kinase reaction
bu¡er (10 mM HEPES pH 7.4, 5 mM MnCl2, 5 mg/ml poly(Glu/Tyr)
4:1, 15 WM unlabeled ATP, 3 WCi [Q-32P]ATP). Reactions were
stopped after 15 min incubation at 30‡C by adding 50 Wl termination
bu¡er (20 mM HEPES pH 7.4, 4 mM ATP, 40 mM EDTA, 2 mg/ml
BSA). Four 10 Wl aliquots of each sample were spotted onto ¢lter
paper squares (Whatman 3 MM) and labeled peptide substrate was
precipitated on the ¢lter paper by immersing the squares in 10% tri-
chloroacetic acid ^ 8% sodium pyrophosphate. Unbound 32P was
removed by washing three times with 5% trichloroacetic acid and
once with 95% ethanol. Radioactivity on the ¢lters was quanti¢ed
by liquid scintillation counting.
3. Results
3.1. Deletion of SH2^kinase linker residues Val177^Tyr184
decreases the catalytic activity of Csk
Shekhtman et al. have shown that the SH3^SH2 linker is
essential for the catalytic activity of Csk [9]. To investigate
whether the SH2^kinase linker is involved in regulation of the
catalytic activity of Csk, residues Val177^Tyr184, within the
SH2^kinase linker, were deleted. This deletion decreased the
catalytic activity of mutant Csk to the same level as kinase-
inactive K222R (Fig. 3A) and vSH3SH2. Because of the en-
dogenous Csk in HeLa cells the reported weak catalytic ac-
tivity of the Csk kinase domain (vSH3SH2) was not seen (Fig.
3A) [15].
3.2. Mutation of Phe183 to Ala decreases the catalytic activity
of Csk
The crystal structure of Csk has revealed a direct associa-
tion of the side chain of Phe183, located within the deleted
segment Val177^Tyr184, with the KC-helix [8]. This suggests
that Phe183 controls the orientation of the KC-helix and the
catalytically critical Glu236 (Fig. 1B). To test this possibility,
Phe183 was mutated to Ala. As shown in Fig. 3A, the F183A
mutant was only slightly functional compared to Csk wt, sug-
gesting that the association of the Phe183 hydrophobic side
chain with the KC-helix is indeed crucial for the catalytic
activity of Csk.
3.3. Mutation of Phe183 to Leu or Trp restores the catalytic
activity of Csk
To test further the hydrophobic interaction between the side
chain of Phe183 and the KC-helix, Phe183 was mutated to
Leu and Trp. The results indicate (Fig. 3A) that the length
and the size of the Phe183 side chain is an important factor in
the interaction of the SH2^kinase linker with the KC-helix.
Both mutations restored the catalytic activity of Csk, Leu
serving a better substitution for Phe183 than Trp. Taken to-
gether these results demonstrate that the hydrophobic associ-
ation of the SH2^kinase linker with the KC-helix via the in-
dole ring of Phe183 is required to maintain the catalytic
activity of the Csk kinase domain.
Fig. 1. A: Structure of active Csk (PDB entry 1K9A [8]) showing
the location of Phe183. Domains and domain linkers are individu-
ally colored: SH3, yellow; SH3^SH2 linker, gray; SH2 domain,
green; SH2^kinase linker, red; kinase domain, blue. B: The major
contact of the SH2^kinase linker with the KC-helix is through
Phe183. The SH3^SH2 linker (Lys72^Pro81), the SH2^kinase linker
(Gly175^Leu190), the L3-strand and the KC-helix (Val219^Leu243)
of the kinase domain are colored as in panel A. Side chains of
Ser78, Phe183, Glu236 and Lys222 are shown in stick representa-
tion. Panels A and B were generated using PyMol [18].
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3.4. E¡ect of Leu223Ala and Leu223Phe point mutations on
the catalytic activity of CHK
Because CHK has a leucine (Leu223) at a position corre-
sponding to Csk Phe183, it was tested if the SH2^kinase link-
er is also involved in the regulation of CHK activity. As
shown in Fig. 3B, mutation of Leu to Ala indeed decreased
the catalytic activity of CHK. To demonstrate that the methyl
side chain of Ala was too short to maintain the catalytic
activity of CHK, Leu223 was mutated to Phe. As shown in
Fig. 3B, this mutation restored the catalytic activity of CHK
compared to the L223A mutant. Altogether these results sug-
gest that the SH2^kinase linker is required to maintain the
catalytic activity of the kinase domain of CHK.
4. Discussion
In the crystal structure of inactive Src, Leu255 within the
SH2^kinase linker binds in a hydrophobic pocket on the sur-
face of the N-terminal lobe of the kinase domain [16]. The
interaction between Leu255 and the kinase domain leads to
the rotation of the KC-helix and disruption of a salt bridge
between Glu310 and Lys295. As a result, catalysis is inhibited
because the displaced Glu310 can no longer align the side
chain of Lys295 to coordinate the phosphate groups of ATP
[10].
In contrast to Src, the SH2^kinase linker of Csk directly
interacts with the KC-helix (Fig. 1B). This suggests that the
SH2^kinase linker could control the movement of the KC-
helix and therefore the formation of an ion pair between
Glu236 (Src Glu310) and Lys222 (Src Lys295) (Fig. 1B).
The decreased activity of Csk vV177-Y184 supports the idea
that the contact of the SH2^kinase linker with the kinase
domain is required to sustain the catalytic activity of Csk.
However, the observed activity of the Csk vV177-Y184 mu-
tant does not give conclusive evidence for the SH2^kinase
linker involvement in Csk activity. Deletion of the SH2^ki-
nase linker residues not only eliminates contacts made by the
deleted residues but also results in the misplacement of the
potential intramolecular interactions N-terminal to the dele-
tion. Therefore the loss of these connections could also con-
tribute to the observed activity of the Csk vV177-Y194 mu-
tant.
Sequence alignment of Src and Csk SH2^kinase linkers re-
veals that Csk has a residue with a long hydrophobic side
chain (Phe183) in a position corresponding to Src Leu255
(Fig. 2A). Phe183 lies within the KBC-helix and the crystal
structure of Csk reveals a hydrophobic interaction of the
Phe183 indole ring with the KC-helix (Fig. 1B). This contact
suggests that the SH2^kinase linker interacts with the KC-
helix via Phe183. Our studies con¢rm that the hydrophobic
Fig. 3. A: Catalytic activity of overexpressed Csk SH2^kinase linker
mutants in HeLa cells. The mutant Csk activity is shown as per-
centage of Csk wt activity with the number of determinations indi-
cated in parentheses. Bars represent the standard deviation of the
mean. B: Catalytic activity of overexpressed CHK SH2^kinase link-
er mutants in COS-1 cells. The mutant CHK activity is shown as
percentage of CHK wt activity with the number of determinations
indicated in parentheses. Bars represent the standard deviation of
the mean.
Fig. 2. A: Alignment of the SH2^kinase domain connecting sequen-
ces of Csk- and Src-family kinases. The KBC-helix in the SH2^ki-
nase linker of Csk is indicated in light gray. Structurally equivalent
residues to Src Leu255 are in bold. The sequences were aligned us-
ing CLUSTAL W [19] and the complete sequence of each kinase.
B: Schematic representation of the deletion and point mutation con-
structs of Csk and FLAG-tagged CHK.
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interaction between Phe183 and the KC-helix is required to
maintain the catalytic activity of Csk. Deletion of the Phe183
indole ring resulted in decreased activity, but the activity
could be restored with a residue possessing a long hydropho-
bic side chain (Leu or Trp). The observed activity of the
F183A mutant suggests that the loss of contact between the
SH2^kinase linker and the KC-helix leads to a greater degree
of freedom in the movement of the KC-helix and therefore to
loss of functional orientation of Glu236. Consequently, the
restoration of the activity of the F183L and F183W mutants
indicates that the long hydrophobic side chains of leucine and
tryptophan can make a contact with the KC-helix and control
the orientation of the KC-helix. These results demonstrate that
the orientation of the KC-helix regulates the catalytic activity
of Csk and a critical parameter controlling the orientation of
KC-helix is a hydrophobic contact between Phe183 and the
KC-helix.
The crystal structure of full-length CHK is still unsolved.
However, the close homology between CHK and Csk suggests
that these kinases share a similar structure. Therefore, the
engagement of the CHK SH2^kinase linker with the KC-helix
could control the activity of the CHK kinase domain. Se-
quence alignment of the CHK and Csk SH2^kinase linkers
supports this hypothesis (Fig. 2A). CHK has a Leu223 within
the SH2^kinase linker in a position corresponding to Csk
Phe183. This conserved hydrophobicity in the CHK SH2^ki-
nase linker favors the possibility that CHK Leu223 is essential
for catalytic activity of CHK, as Phe183 is for Csk. As sug-
gested, deletion of the side chain of Leu223 decreased the
catalytic activity of CHK, whereas activity could be restored
by mutating Leu223 to Phe. Together these results indicate
that Leu223 is necessary for the catalytic activity of the CHK
kinase domain. The most probable explanation for the ob-
tained results is that Leu223 makes a hydrophobic contact
with the KC-helix and controls the orientation of the catalyti-
cally critical Glu276 (Csk Glu236), in a manner analogous to
Csk Phe183.
Previous studies have indicated that mutation of the SH3^
SH2 linker residues also decrease the catalytic activity of Csk
[9,17]. The SH3^SH2 linker residue Ser78 was mutated in
both studies. Because Ser78 makes contact with the SH2^ki-
nase linker (Fig. 1B), it is possible, that the SH3^SH2 linker
mutation results in weaker contact between linkers. Presum-
ably a weak contact between the SH3^SH2^ and SH2^kinase
linkers allows a higher degree of movement of the KBC-helix
on top of the N-terminal lobe of the kinase domain. As a
result, catalytic activity decreases because Phe183 in the
KBC-helix cannot contact the KC-helix to support the catalyti-
cally active conformation of the KC-helix.
In conclusion, our data indicate that, in contrast to Src,
conserved hydrophobicity within the SH2^kinase linker is re-
quired to maintain the catalytic activity of Csk and CHK.
These data provide evidence that interaction between the
SH2^kinase linker and the KC-helix is required for formation
of a functional catalytic domain of Csk-family kinases.
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